Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Induced Pluripotent Stem Cells | 1 | 2023 | 208 | 0.710 |
Why?
|
| Transcription Factors | 1 | 2023 | 2337 | 0.420 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2023 | 18 | 0.210 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2026 | 541 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2026 | 774 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 359 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2021 | 38 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2023 | 538 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 127 | 0.160 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 211 | 0.160 |
Why?
|
| Dopamine | 1 | 2021 | 246 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2023 | 968 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 650 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 609 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 1302 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 350 | 0.140 |
Why?
|
| Monocytes | 1 | 2020 | 330 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 2310 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 57 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 124 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 711 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 272 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 1193 | 0.100 |
Why?
|
| Mice | 4 | 2023 | 17596 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 980 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1370 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 730 | 0.090 |
Why?
|
| Neoplasms | 1 | 2026 | 2855 | 0.090 |
Why?
|
| Animals | 5 | 2023 | 33051 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 701 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2304 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2582 | 0.070 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 133 | 0.060 |
Why?
|
| Humans | 7 | 2026 | 126753 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 6668 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2022 | 66 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4504 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 2020 | 32 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 422 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 300 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 2 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 29 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2017 | 35 | 0.030 |
Why?
|
| Albuterol | 1 | 2017 | 52 | 0.030 |
Why?
|
| Propranolol | 1 | 2017 | 111 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 181 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 477 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 214 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 155 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 270 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 729 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 20344 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 502 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1204 | 0.030 |
Why?
|
| Middle Aged | 2 | 2026 | 27697 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2397 | 0.020 |
Why?
|
| Adult | 2 | 2026 | 30410 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1377 | 0.020 |
Why?
|
| Female | 3 | 2026 | 68330 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3498 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4429 | 0.020 |
Why?
|
| Male | 2 | 2026 | 62543 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9665 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 14347 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 20002 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17005 | 0.010 |
Why?
|
| Child | 1 | 2021 | 25101 | 0.010 |
Why?
|